Schedule 13G ownership disclosure
Protalix BioTherapeutics, Inc.
Security class unavailable · CUSIP: 74365A101
Event date: 2015-10-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.7100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-15-003115
- Form type
- SC 13G
- Filer
- MEITAV INVESTMENT HOUSE LTD
- CIK
- CIK 1398346
- Filed
- Oct 22, 2015
- Reporting period
- Oct 21, 2015
- Description
- Schedule 13G beneficial ownership